Abstract
The tachykinin family of peptides are distributed throughout the nervous system and are thought to play a critical role in inflammation and immunomodulation. Tachykinins have been implicated in the pathogenesis of many diseases and disease processes including inflammatory pain, emesis, depression, Parkinson's disease and inflammatory bowel syndrome. In the airways of animals, substance P and neurokinin A are released from a subset of airway sensory nerves, and evoke vasodilatation, bronchoconstriction, mucus secretion, leukocyte recruitment, airways hyperreactivity and cough. These observations have led to suggestions that tachykinins may also be viable targets for the treatment of obstructive airways disease. Clinical trials in humans assessing the utility of tachykinin receptor antagonists such as nepadutant and saredutant for the treatment of asthma are limited, and the results for the most part have been inconclusive. Several new tachykinin receptor antagonists have been recently designed to target multiple tachykinin receptor subtypes and to readily penetrate into the central nervous system. Future clinical trials with these compounds should help to shed some light on the role of tachykinins in obstructive airways disease.
References
Jan 1, 1991·Life Sciences·N Frossard, C Advenier
Jan 1, 1991·Life Sciences·S BrunelleschiR Fantozzi
Jan 1, 1991·International Archives of Allergy and Applied Immunology·P H HowarthJ M Polak
Jan 1, 1991·International Archives of Allergy and Applied Immunology·K NieberG Kunkel
Jan 1, 1986·International Archives of Allergy and Applied Immunology·H AliJ C Foreman
Jan 1, 1988·General Pharmacology·C A Maggi, A Meli
Jan 1, 1987·International Archives of Allergy and Applied Immunology·K AlvingS Ahlstedt
Jan 1, 1984·Cell and Tissue Research·J M LundbergC Cuello
Jan 1, 1996·European Journal of Clinical Pharmacology·D SchmidtH Magnussen
Jan 1, 1996·Lung·W MarekX Baur
Jan 1, 1997·Lung·B S LoefflerL Y Lee
Aug 26, 1999·Respiration; International Review of Thoracic Diseases·M BodelssonK Törnebrandt
Mar 17, 2000·Pulmonary Pharmacology & Therapeutics·F E WoisinC P Page
Mar 29, 2001·Pulmonary Pharmacology & Therapeutics·P J MauserR W Chapman
Jun 7, 2003·Blood·Yu Zhang, Christopher J Paige
Dec 3, 2003·American Journal of Respiratory and Critical Care Medicine·Jesse P JoadAnn C Bonham
Jan 24, 2004·The European Respiratory Journal·G F JoosR A Pauwels
May 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ahmed MetwaliJoel V Weinstock
Jun 30, 2004·Cellular and Molecular Life Sciences : CMLS·N M Page
Feb 28, 1901·The Journal of Physiology·W M Bayliss
Citations
Aug 24, 2007·Clinical and Experimental Pharmacology & Physiology·Stuart B Mazzone, Alice E McGovern
Jan 15, 2014·Autonomic Neuroscience : Basic & Clinical·Alice E McGovern, Stuart B Mazzone
Aug 19, 2008·European Journal of Pharmacology·Hiroshi TsuchidaKiyoshi Morimoto
May 9, 2008·Pulmonary Pharmacology & Therapeutics·Brendan J Canning, Yangling Chou
Mar 21, 2008·European Journal of Pharmacology·Hiroshi TsuchidaKiyoshi Morimoto
May 30, 2008·Allergy·G A MostafaS A Ahmed
Sep 6, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Eleni G TzortzakiNikolaos M Siafakas
Jun 13, 2006·Japanese Journal of Ophthalmology·Nobuyuki EbiharaAkira Murakami
Dec 17, 2005·Current Opinion in Pulmonary Medicine·Esteban J Morcillo, Julio Cortijo
Dec 3, 2014·Current Protocols in Pharmacology·Alice E McGovern, Stuart B Mazzone
Nov 10, 2018·The Journal of Allergy and Clinical Immunology·Alice E McGovernStuart B Mazzone